Republished review. [corrected] Late-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration
- PMID: 19734518
- DOI: 10.1136/bjo.2008.150151
Republished review. [corrected] Late-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration
Erratum in
- Postgrad Med J. 2011 Nov;87(1033):792
Abstract
Aim: This study describes, in detail, the phenotype of late-onset retinal macular degeneration (L-ORMD) an inherited condition affecting both the retina and anterior segment. A staging based on clinical characteristics is proposed, and the relevance of this condition to current understanding of age-related macular degeneration is discussed.
Methods: A systematic review of the literature regarding this condition supports a detailed description of the natural history. Clinical experiences in identifying, monitoring and managing patients are also presented.
Results: L-ORMD is a rare fully penetrant autosomal dominant condition resulting from a mutation in the C1QTNF5 gene on chromosome 11. Affected individuals develop bilateral loss of vision, dark-adaptation abnormalities, fundus drusen-like yellow spots, midperipheral pigmentation, choroidal neovascularisation, chorioretinal atrophy and long anteriorly inserted lens zonules. Patients may benefit from treatment with high-dose vitamin A.
Conclusions: Raised awareness of L-ORMD should lead to earlier diagnosis and improved care for patients. New antivascular endothelial growth factor treatment may provide a new possibility for management. A deeper insight into molecular and genetic mechanisms of L-ORMD may suggest avenues to explore new treatments of this disorder.
Republished from
-
Late-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration.Br J Ophthalmol. 2009 Mar;93(3):284-9. doi: 10.1136/bjo.2008.150151. Epub 2008 Dec 19. Br J Ophthalmol. 2009. PMID: 19098033
Grants and funding
LinkOut - more resources
Full Text Sources